# EDGAR Filing Document

**Accession Number:** 0000879682
**File Stem:** 0001437749-23-002587
**Filing Date:** 2023-2
**Character Count:** 2955
**Document Hash:** b8a11d06289ff9c8b45ad9fc3107128f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-23-002587.hdr.sgml**: 20230206

**ACCESSION NUMBER**: 0001437749-23-002587

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230206

**DATE AS OF CHANGE**: 20230206

**EFFECTIVENESS DATE**: 20230206

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VIVEVE MEDICAL, INC.
- **CENTRAL INDEX KEY:** 0000879682
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **IRS NUMBER:** 043153858
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11388
- **FILM NUMBER:** 23590646

**BUSINESS ADDRESS:**
- **STREET 1:** 345 INVERNESS DRIVE SOUTH
- **STREET 2:** BUILDING B, SUITE 250
- **CITY:** ENGLEWOOD
- **STATE:** CO
- **ZIP:** 80112
- **BUSINESS PHONE:** 4085301900

**MAIL ADDRESS:**
- **STREET 1:** 345 INVERNESS DRIVE SOUTH
- **STREET 2:** BUILDING B, SUITE 250
- **CITY:** ENGLEWOOD
- **STATE:** CO
- **ZIP:** 80112

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PLC SYSTEMS INC
- **DATE OF NAME CHANGE:** 19930328

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 15** 

------

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION** 

**UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF** 

**THE SECURITIES EXCHANGE ACT OF 1934.** 

**001-11388** 

**Commission File Number** 

------

## VIVEVE MEDICAL, INC.
**(Exact name of registrant as specified in its charter)** 

------

**Viveve Medical, Inc.** 

**345 Inverness Drive South**

**Building B, Suite 250**

**Englewood, CO 80112**

**(720) 696-8100**

**(Address, including zip code, and telephone number, including area code, of registrant**'**s principal executive offices)** 

**Common Stock, $0.0001 par value per share** 

**(Title of each class of securities covered by this Form)** 

**None** 

**(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)** 

------

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
| Rule 12g-4(a)(1) | ☒ |
| Rule 12g-4(a)(2) | ☐ |
| Rule 12h-3(b)(1)(i) | ☒ |
| Rule 12h-3(b)(1)(ii) | ☐ |
| Rule 15d-6 | ☐ |
| Rule 15d-22(b) | ☐ |

---

Approximate number of holders of record as of the certification or notice date: 94

Pursuant to the requirements of the Securities Exchange Act of 1934, Viveve Medical, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | | |
|:---|:---|:---|
| Date: February 6, 2023 | By: | /s/ Scott Durbin |
|  | Name: | Scott Durbin |
|  | Title: | Chief Executive Officer |

---

------